Prevalence and Potential Risk Factors of Helicobacter pylori Infection among Asymptomatic Individuals in Kazakhstan.
Gastric cancer
Helicobacter pylori
Kazakhstan
Prevalence
risk factors
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
received:
15
11
2020
entrez:
28
2
2021
pubmed:
1
3
2021
medline:
9
11
2021
Statut:
epublish
Résumé
Helicobacter pylori (H. pylori) infection is associated with several risk factors such as demographic, socioeconomic status and personal habits, which vary in different populations. This is the most up-to-date data on H. pylori prevalence and potential risk factors for H. pylori infection among asymptomatic middle-aged individuals in Kazakhstan. Apparently healthy individuals aged 40 to 64, who took part in the health control in the outpatient clinic, were invited to participate in the study; answered a questionnaire, donated a blood sample. The antibodies to H. pylori were analysed by latex agglutination method. The baseline characteristics of study subjects with or without H. pylori infection were compared using the Chi-square test. Odds ratio (OR) and 95% confidence intervals (CI) for the association between H. pylori infection and potential risk factors were estimated using multivariable logistic regression models. Altogether 166 subjects (59% male; the median age - 51 years old) were included; 104 (62.7%) were H. pylori positive. There were no statistically significant differences between H. pylori positive and H. pylori negative groups in respect to the gender, anthropometric measurements, socioeconomic factors and personal habits. The multiple variable analysis showed that age (OR, 1.99; 95% CI, 1.03 - 3.86; P=0.04) and increased salt intake (OR, 2.21; 95% CI, 1.12 - 4.35; P=0.02) were associated with H. pylori infection. More than half of the study subjects were infected with H. pylori in Kazakhstan. The prevalence of H. pylori infection was independently associated with older age and regular high salt consumption.
Sections du résumé
BACKGROUND
Helicobacter pylori (H. pylori) infection is associated with several risk factors such as demographic, socioeconomic status and personal habits, which vary in different populations. This is the most up-to-date data on H. pylori prevalence and potential risk factors for H. pylori infection among asymptomatic middle-aged individuals in Kazakhstan.
METHODS
Apparently healthy individuals aged 40 to 64, who took part in the health control in the outpatient clinic, were invited to participate in the study; answered a questionnaire, donated a blood sample. The antibodies to H. pylori were analysed by latex agglutination method. The baseline characteristics of study subjects with or without H. pylori infection were compared using the Chi-square test. Odds ratio (OR) and 95% confidence intervals (CI) for the association between H. pylori infection and potential risk factors were estimated using multivariable logistic regression models.
RESULTS
Altogether 166 subjects (59% male; the median age - 51 years old) were included; 104 (62.7%) were H. pylori positive. There were no statistically significant differences between H. pylori positive and H. pylori negative groups in respect to the gender, anthropometric measurements, socioeconomic factors and personal habits. The multiple variable analysis showed that age (OR, 1.99; 95% CI, 1.03 - 3.86; P=0.04) and increased salt intake (OR, 2.21; 95% CI, 1.12 - 4.35; P=0.02) were associated with H. pylori infection.
CONCLUSIONS
More than half of the study subjects were infected with H. pylori in Kazakhstan. The prevalence of H. pylori infection was independently associated with older age and regular high salt consumption.
Identifiants
pubmed: 33639679
doi: 10.31557/APJCP.2021.22.2.597
pmc: PMC8190350
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
597-602Références
BMJ Open. 2017 Aug 11;7(8):e016999
pubmed: 28801429
Clin Microbiol Rev. 2010 Oct;23(4):713-39
pubmed: 20930071
Int J Environ Res Public Health. 2018 Nov 19;15(11):
pubmed: 30463266
J Formos Med Assoc. 2014 May;113(5):278-83
pubmed: 24389268
PLoS One. 2015 Nov 23;10(11):e0140186
pubmed: 26599790
J Gastroenterol Hepatol. 2000 Mar;15(3):271-6
pubmed: 10764027
Anticancer Res. 2013 Oct;33(10):4595-602
pubmed: 24123036
Nagoya J Med Sci. 2010 Aug;72(3-4):167-72
pubmed: 20942272
J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:16-9
pubmed: 25521727
Asian Pac J Cancer Prev. 2019 Dec 01;20(12):3825-3829
pubmed: 31870128
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Asian Pac J Cancer Prev. 2012;13(6):2481-4
pubmed: 22938408
Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):34-39
pubmed: 29201769
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Scand J Gastroenterol. 1997 Jul;32(7):651-5
pubmed: 9246703
Helicobacter. 2014 Dec;19(6):437-42
pubmed: 25256639
Nihon Rinsho. 2003 Jan;61(1):36-40
pubmed: 12607312
J Water Health. 2010 Mar;8(1):192-203
pubmed: 20009261
Gastroenterol Res Pract. 2013;2013:494783
pubmed: 24174932
Eksp Klin Gastroenterol. 2015;(6):16-20
pubmed: 26817100
World J Gastroenterol. 2009 May 14;15(18):2204-13
pubmed: 19437559
Aliment Pharmacol Ther. 2014 Jul;40(1):24-31
pubmed: 24832176
Prz Gastroenterol. 2019;14(1):26-38
pubmed: 30944675
Am J Trop Med Hyg. 2002 Aug;67(2):201-6
pubmed: 12389948
Gastroenterology. 2017 Aug;153(2):420-429
pubmed: 28456631
BMC Gastroenterol. 2019 Nov 14;19(1):186
pubmed: 31726980
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593